Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 71-80 of 1154 total displayed.

Past content (since Jan 1999):

Correspondence
Response to Letter Regarding Article, "Acute Pharmacological Conversion of Atrial Fibrillation to Sinus Rhythm"
William R. Hiatt, A. Michael Lincoff, and Robert A. Harrington
Circulation 2009;119:e18, doi:10.1161/CIRCULATIONAHA.108.816371 [Full text]  

Editorials
Antihypertensive Efficacy of Aliskiren: Is Hydrochlorothiazide an Appropriate Benchmark?
Franz H. Messerli and Sripal Bangalore
Circulation 2009;119:371-373, doi:10.1161/CIRCULATIONAHA.108.828897 [Full text]  

Articles
Altered Bone Morphogenetic Protein and Transforming Growth Factor-{beta} Signaling in Rat Models of Pulmonary Hypertension. Potential for Activin Receptor-Like Kinase-5 Inhibition in Prevention and Progression of Disease
Lu Long, Alexi Crosby, Xudong Yang, Mark Southwood, Paul D. Upton, Dae-Kee Kim, and Nicholas W. Morrell
Circulation published January 19, 2009, doi:10.1161/CIRCULATIONAHA.108.821504 [Abstract]  

Articles
Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003. A Population Study of 5.1 Million People
Pardeep S. Jhund, Kate MacIntyre, Colin R. Simpson, James D. Lewsey, Simon Stewart, Adam Redpath, James W.T. Chalmers, Simon Capewell, and John J.V. McMurray
Circulation published January 19, 2009, doi:10.1161/CIRCULATIONAHA.108.812172 [Abstract]  

Contemporary Reviews in Cardiovascular Medicine
Neurogenic Orthostatic Hypotension: A Pathophysiological Approach
David S. Goldstein and Yehonatan Sharabi
Circulation 2009;119:139-146, doi:10.1161/CIRCULATIONAHA.108.805887 [Full text]  

Heart Disease in Asia
Pharmacological Intervention for Prevention of Left Ventricular Remodeling and Improving Prognosis in Myocardial Infarction
Hideki Ishii, Tetsuya Amano, Tatsuaki Matsubara, and Toyoaki Murohara
Circulation 2008;118:2710-2718, doi:10.1161/CIRCULATIONAHA.107.748772 [Full text]  

Coronary Heart Disease
Angiotensin II Type 2 Receptor Stimulation: A Novel Option of Therapeutic Interference With the Renin-Angiotensin System in Myocardial Infarction?
Elena Kaschina, Aleksandra Grzesiak, Jun Li, Anna Foryst-Ludwig, Melanie Timm, Franziska Rompe, Manuela Sommerfeld, U. Rudolf Kemnitz, Caterina Curato, Pawel Namsolleck, Carsten Tschöpe, Anders Hallberg, Mathias Alterman, Thomas Hucko, Ingo Paetsch, Thore Dietrich, Bernhard Schnackenburg, Kristof Graf, Björn Dahlöf, Ulrich Kintscher, Thomas Unger, and U. Muscha Steckelings
Circulation 2008;118:2523-2532; published online before print as doi:10.1161/CIRCULATIONAHA.108.784868 [Abstract] [Full text]  

ACC/AHA Performance Measures
ACC/AHA 2008 Statement on Performance Measurement and Reperfusion Therapy: A Report of the ACC/AHA Task Force on Performance Measures (Work Group to Address the Challenges of Performance Measurement and Reperfusion Therapy)
WRITING COMMITTEE MEMBERS, Frederick A. Masoudi, Robert O. Bonow, Ralph G. Brindis, Christopher P. Cannon, Jo DeBuhr, Susan Fitzgerald, Paul A. Heidenreich, Kalon K.L. Ho, Harlan M. Krumholz, Chris Leber, David J. Magid, David S. Nilasena, John S. Rumsfeld, Sidney C. Smith, Jr, and Thomas P. Wharton, Jr
Circulation 2008;118:2649-2661; published online before print as doi:10.1161/CIRCULATIONAHA.108.191100 [Full text]  

Heart Failure
Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Barry R. Davis, John B. Kostis, Lara M. Simpson, Henry R. Black, William C. Cushman, Paula T. Einhorn, Michael A. Farber, Charles E. Ford, Daniel Levy, Barry M. Massie, Shah Nawaz for the ALLHAT Collaborative Research Group
Circulation 2008;118:2259-2267; published online before print as doi:10.1161/CIRCULATIONAHA.107.762229 [Abstract] [Full text]  

Articles
Angiotensin II Type 2 Receptor Stimulation. A Novel Option of Therapeutic Interference With the Renin-Angiotensin System in Myocardial Infarction?
Elena Kaschina, Aleksandra Grzesiak, Jun Li, Anna Foryst-Ludwig, Melanie Timm, Franziska Rompe, Manuela Sommerfeld, U. Rudolf Kemnitz, Caterina Curato, Pawel Namsolleck, Carsten Tschöpe, Anders Hallberg, Mathias Alterman, Thomas Hucko, Ingo Paetsch, Thore Dietrich, Bernhard Schnackenburg, Kristof Graf, Björn Dahlöf, Ulrich Kintscher, Thomas Unger, and U. Muscha Steckelings
Circulation published November 24, 2008, doi:10.1161/CIRCULATIONAHA.108.784868 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment